MurryLoraine
NewYork
Sell:
5CL-ADB supplier 5cladba 5cladb China supplier
Offer added:
08-11-2024
Valid until
28-11-2029
Location
英国英格兰,
Condition
New
Contact us if you are interested: Telegram/Signal/Skype/WhatsApp : +852 53076882 Hot-sale products: 5cl-adba precursor (semi finished ) 5cl-adba raw materials ADBB precursor (semi finished ) ADBB raw materials APVP powder 5fadb/4f-adb Jwh018 / Jwh210 Eutylone crystal Isotonitazene CAS: 14188-81-9 Fluetizolam CAS: 40054-88-4 Bromazolam CAS: 71368-80-4 Protonitazene (hydrochloride) CAS: 119276-01-6 Flubrotizolam CAS: 57801-95-3 Metonitazene CAS: 14680-51-4
Delivery
Pickup in person 0.00 zł
Polish Post 0.00 zł
Courier 0.00 zł
Shipping abroad (ask for the price) 0.00 zł
Parcel locker 0.00 zł
Polish Post (cash on delivery) 0.00 zł
Courier (cash on delivery) 0.00 zł
Payment option
Transfer (after pickup)
Cash (on delivery)
Transfer (in advance)
MurryLoraine
NewYork
Seller's other items
Sell:
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale
AEG/AEP/TW
英国英格兰
5.00 zł
Sell:
5cladb,adbb,jwh018,4fadb 137350-66-4 Synthetic cannabinoid precursors, Raw materials
AEG/AEP/TW
英国英格兰
5.00 zł
Sell:
5CL-ADB-A,5CLADBA strong 5cladb 5-cl-adb 5cl-adb p by 5cladb
AEG/AEP/TW
英国英格兰
5.00 zł
Sell:
6cl Strong 5cladb ADBB 5F-ADB 5cladb jwh018 for sale
AEG/AEP/TW
英国英格兰
5.00 zł
Sell:
6cl 5f-adbprecursor,-eutylone,-2fdck,-jwh018,-5cl-adb
AEG/AEP/TW
英国英格兰
5.00 zł
Sell:
5cladb-a, 5cl-adb-a, 5clbca, 5cl-bca, 5cl-bca, 5cl
AEG/AEP/TW
英国英格兰
5.00 zł
See also
Sell:
Replika AKS74u CM.045
AEG/AEP/TW
Tarnobrzeg, Polska
360.00 zł
Sell:
Glock 17 WE dwa magi plus kabura
AEG/AEP/TW
Wrocław, Polska
550.00 zł
Sell:
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale
AEG/AEP/TW
英国英格兰
5.00 zł
Sell:
5cladb,adbb,jwh018,4fadb 137350-66-4 Synthetic cannabinoid precursors, Raw materials
AEG/AEP/TW
英国英格兰
5.00 zł
Sell:
5CL-ADB-A,5CLADBA strong 5cladb 5-cl-adb 5cl-adb p by 5cladb
AEG/AEP/TW
英国英格兰
5.00 zł
Loading...
Search phrase is too short. The phrase must have at least 3 signs.
Comments